NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIDDK E-109-2006-0-CH-09 Adenosine Derivatives, Method For The Synthesis Thereof, And The Pharmaceutical Compositions For The Prevention And Treatment Of The Inflammatory Diseases Containing The Same As An Active Ingredient CH EP 07715531.5 Issued
NIDDK E-109-2006-0-FR-11 Adenosine Derivatives, Method For The Synthesis Thereof, And The Pharmaceutical Compositions For The Prevention And Treatment Of The Inflammatory Diseases Containing The Same As An Active Ingredient FR EP 07715531.5 Issued
NIDDK E-109-2006-0-DE-10 Adenosine Derivatives, Method For The Synthesis Thereof, And The Pharmaceutical Compositions For The Prevention And Treatment Of The Inflammatory Diseases Containing The Same As An Active Ingredient DE EP 07715531.5 Issued
NIDDK E-109-2006-0-JP-06 Adenosine Derivatives, Method For The Synthesis Thereof, And The Pharmaceutical Compositions For The Prevention And Treatment Of The Inflammatory Diseases Containing The Same As An Active Ingredient JP National Stage 2009552570 Issued
NCI E-307-2004-1-US-01 O6-ALKYLGUANINE-DNA ALKYLTRANSFERASE INACTIVATORS AND BETA-GLUCURONIDASE CLEAVABLE PRODRUGS US CIP 11/683,310 7825096 Abandoned PDF
NIDDK E-109-2006-0-CN-08 Adenosine Derivatives, Method For The Synthesis Thereof, And The Pharmaceutical Compositions For The Prevention And Treatment Of The Inflammatory Diseases Containing The Same As An Active Ingredient CN National Stage 200780052031.X Issued
NCI E-200-2001-0-US-03 Agents that Bind To And Inhibit Human Cytochrome [P450 2C19] US DIV 11/683,229 7682800 Expired PDF
NIDDK E-109-2006-0-PCT-01 Adenosine Derivatives, Method For The Synthesis Thereof, And The Pharmaceutical Compositions For The Prevention And Treatment Of The Inflammatory Diseases Containing The Same As An Active Ingredient PCT PCT PCT/KR2007/001131 Expired
NCI E-132-2007-1-US-01 The Combination Of HA22 (CAT-8015) With Standard Chemotherapeutic Agents On A Human Burkitt Lymphoma Cell Line US 60/893,596 Abandoned
NIDDK E-248-2004-0-US-09 PURINE DERIVATIVES AS A3 AND A1 ADENOSINE RECEPTOR AGONISTS US National Stage 11/574,779 7825126 Abandoned PDF
NCI E-090-2006-0-PCT-02 Immunotherapy With Natural Killer Cells Expanded Ex Vivo After Nonmyeloablative Lymphodepleting Chemotherapy PCT PCT PCT/US2007/063352 Expired
NIEHS E-057-2005-0-PCT-02 Glycated Peptides And Methods Of Use PCT PCT PCT/US2007/63385 Expired
NCI E-090-2006-0-EP-05 Autologous Natural Killer Cells And Lymphodepleting Chemotherapy For The Treatment Of Cancer EP National Stage 07757951.4 Abandoned
NIDA E-025-2007-0-US-01 TREATMENT OF COCAINE-INDUCED FETAL BRAIN INJURY US 60/893,218 Abandoned
NCI E-090-2006-0-AU-03 Autologous Natural Killer Cells And Lymphodepleting Chemotherapy For The Treatment Of Cancer AU National Stage 2007223093 Abandoned
NINDS E-085-2006-0-PCT-02 Real-time Correction Of Magnetic Field Fluctuations In MRI PCT PCT PCT/US07/005826 Abandoned
NCI E-090-2006-0-CA-04 Autologous Natural Killer Cells And Lymphodepleting Chemotherapy For The Treatment Of Cancer CA National Stage 2645042 Abandoned
CC E-170-2004-0-FR-06 Second Generation Integrin Avb3 Antagonists For Use In Imaging And Therapy FR EP 05807519.3 Issued
CC E-170-2004-0-DE-05 Second Generation Integrin Avb3 Antagonists For Use In Imaging And Therapy DE EP 05807519.3 Issued
CC E-170-2004-0-CH-04 Second Generation Integrin Avb3 Antagonists For Use In Imaging And Therapy CH EP 05807519.3 Issued
CC E-170-2004-0-IE-07 Second Generation Integrin Avb3 Antagonists For Use In Imaging And Therapy IE EP 05807519.3 Issued
NCI E-132-2006-2-PCT-01 MATERIALS AND METHODS DIRECTED TO ASPARAGINE SYNTHETASE AND ASPARAGINASE THERAPIES PCT PCT COMB PCT/US2007/005555 Expired
NCI E-132-2007-0-US-01 The Combination Of HA22 (CAT-8015) With Standard Chemotherapeutic Agents On A Human Burkitt Lymphoma Cell Line US 60/892,819 Abandoned
NHLBI E-114-2007-0-US-01 Optical Slice Motion Tracker US 60/904,683 Abandoned
NIBIB E-098-2005-0-US-02 Systems and Methods for Organ Assessment US ORD 11/713,270 Abandoned
NIDCR E-035-2010-2-US-02 INTEGRIN CD18 IS A NOVEL STROMAL STEM CELL MARKER AND FUNCTIONS TO PROMOTE OSTEOGENESIS US National Stage 11/574,581 7732126 Issued PDF
NCI E-074-2007-0-US-01 The Use Of Human T-box Transcription Factor Brachyury As A Target For Cancer Imrnunotherapy And The Identification Of Epitopes Of Human Brachyury As Targets For Tcell Mediated Lysis Of Tumors US 60/904,236 Abandoned
NHLBI E-276-2004-2-US-06 Methods for Assessing Atherosclerosis by Measuring Expression of FOS or DUSP1 In Monocytes US National Stage 11/661,714 7998682 Issued PDF
NCI E-120-2007-0-US-01 Mesothelin Expression In Human Lung Cancer US 60/891,923 Abandoned
NCI E-086-2007-0-US-01 Radiolabeling Of Affibody Molecules With F-18 US 60/891,875 Abandoned
NCI E-084-2007-0-US-01 The Use Of Histone Deacetylase (HDAC) Inhibitors For The Prevention And Cure Of Breast Cancer Brain Metastasis US 60/891,856 Abandoned
NIDDK E-199-2007-0-US-01 Single Electrode Electrochemical/Electrospray Ionization Corona Discharge Electrochemical Electrospray Ionization US 60/903,772 Abandoned
NIAID E-337-2004-0-US-08 Recombinant MVA Viruses Expressing Clade A/G And Clade B Modified HIV Env, Gag, And Pol Genes US National Stage 11/574,285 9453239 Issued PDF
NCI E-233-2004-0-US-03 A COMMENSAL STRAIN OF E. COLI ENCODING AN HIV GP41 PROTEIN (Issued)
Live Microbial Microbiocides (as filed) 		US CON 11/710,512 8349586 Issued PDF
NIDA E-134-2006-0-US-02 Methods for decreasing the toxicity effects of nicotine on fetuses in pregnant women US National Stage 11/679,022 7547712 Issued PDF
NIAID E-074-2006-0-US-05 Method Of Using Adenoviral Vectors With Increased Immunity In Vivo US National Stage 11/678,947 Abandoned
NCI E-125-2006-2-PCT-01 EXTRACELLULAR MATRIX/METASTASIS MODIFER GENES FOR THE PREVENTION OR INHIBITION OF METASTASIS OR GROWTH OF TUMOR AND FOR CHARACTERIZATION OF TUMOR PCT PCT COMB PCT/US2007/004767 Expired
NCI E-072-2004-4-PCT-01 HIV TEV Compositions And Methods Of Use PCT PCT COMB PCT/US20070004694 Expired
NCI E-125-2006-2-EP-04 EXTRACELLULAR MATRIX/METASTASIS MODIFER GENES FOR THE PREVENTION OR INHIBITION OF METASTASIS OR GROWTH OF TUMOR AND FOR CHARACTERIZATION OF TUMOR EP National Stage 07751522.9 Abandoned
NIAID E-123-2007-0-US-01 Chimpaneze Monoclonal Antibodies That Neutralize Lethal And Edema Factors Of Anthrax Toxin US 60/903,022 Abandoned
NCI E-016-2006-0-US-01 ANTIBODIES THAT SPECIFICALLY BIND IRTA AND METHODS OF USE US 60/891,434 Abandoned
NCI E-125-2006-2-CA-03 EXTRACELLULAR MATRIX/METASTASIS MODIFER GENES FOR THE PREVENTION OR INHIBITION OF METASTASIS OR GROWTH OF TUMOR AND FOR CHARACTERIZATION OF TUMOR CA National Stage 2644426 Abandoned
NCI E-125-2006-2-AU-02 EXTRACELLULAR MATRIX/METASTASIS MODIFER GENES FOR THE PREVENTION OR INHIBITION OF METASTASIS OR GROWTH OF TUMOR AND FOR CHARACTERIZATION OF TUMOR AU National Stage 2007221234 Abandoned
NCI E-106-2006-2-PCT-01 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE PCT PCT COMB PCT/US2007/004454 Expired
NIAID E-126-2007-0-US-01 SUPPRESSION OF ALLERGIC ASTHMA BY ASCARIS ABA-1 ANTIGEN US 60/902,506 Abandoned
NCI E-104-2006-0-CA-04 IMMUNOGENIC PEPTIDES AND METHODS OF USE CA National Stage 2642994 Issued
NCI E-104-2006-0-AU-03 IMMUNOGENIC PEPTIDES AND METHODS OF USE AU National Stage 2007221255 Issued
NCI E-104-2006-0-ES-10 IMMUNOGENIC PEPTIDES AND METHODS OF USE ES EP 07751371.1 Issued
NCI E-104-2006-0-SE-16 IMMUNOGENIC PEPTIDES AND METHODS OF USE SE EP 07751371.1 Issued
NCI E-104-2006-0-DK-08 IMMUNOGENIC PEPTIDES AND METHODS OF USE DK EP 07751371.1 Issued